Evidence map›Paper›PMID 16166590›Full record

ArticleBlood2006

Novel collectin/C1q receptor mediates mast cell activation and innate immunity.

Brian T Edelson, Thomas P Stricker, Zhengzhi Li, S Kent Dickeson, Virginia L Shepherd, Samuel A Santoro, Mary M Zutter

Abstract read
In one paragraph

Article in Blood, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Tropical medicine and infectious disease · 2023
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. C1q: A fresh look upon an old molecule.Molecular immunology · 2017
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Regulation of mast cell responses in health and disease.Critical reviews in immunology · 2011
    Review
  16. Article
  17. Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2010
    Article
  18. Article
  19. Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  20. Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brian T EdelsonDepartment of Pathology, Washington University School of Medicine, St Louis, MO, USA.
Thomas P Stricker
Zhengzhi Li
S Kent Dickeson
Virginia L Shepherd
Samuel A Santoro
Mary M Zutter

Funding

The alpha2beta1 Integrin: Innate Immunity to Pathogens & TumorsR01CA098027 · NCI · WASHINGTON UNIVERSITY · PI ZUTTER, MARY M. · 2003 to 2013
$3.3M
ALTERED ALPHA-2 INTEGRIN EXPRESSION IN BREAST CANCERR01CA070275 · NCI · WASHINGTON UNIVERSITY · PI ZUTTER, MARY M. · 1996 to 2005
$1.8M
NCI NIH HHS CA98027NCI NIH HHS R01CA70275
6 · The paper itself

Abstract

Mast cells play a critical role in innate immunity, allergy, and autoimmune diseases. The receptor/ligand interactions that mediate mast cell activation are poorly defined. The alpha2beta1 integrin, a receptor for collagens, laminins, decorin, E-cadherin, matrix metalloproteinase-1 (MMP-1), endorepellin, and several viruses, has been implicated in normal developmental, inflammatory, and oncogenic processes. We recently reported that alpha2 integrin subunit-deficient mice exhibited markedly diminished neutrophil and IL-6 responses during Listeria monocytogenes- and zymosan-induced peritonitis. Peritoneal mast cells require alpha2beta1 integrin expression for activation in response to pathogens, yet the ligand and molecular mechanisms by which the alpha2beta1 integrin induces activation and cytokine secretion remain unknown. We now report that the alpha2beta1 integrin is a novel receptor for multiple collectins and the C1q complement protein. We demonstrate that the alpha2beta1 integrin provides a costimulatory function required for mast cell activation and cytokine secretion. This finding suggests that the alpha2beta1 integrin is not only important for innate immunity but may serve as a critical target for the regulation of autoimmune/allergic disorders.

Indexed as

Immunity, InnateAnimalsAntigen-Antibody ComplexCollectinsCytokinesIntegrin alpha2beta1Interleukin-6LigandsMast CellsMembrane GlycoproteinsMiceMice, KnockoutPeritoneumProtein BindingReceptors, ComplementAntigen-Antibody ComplexCollectinscomplement 1q receptorCytokinesIntegrin alpha2beta1Interleukin-6LigandsMembrane GlycoproteinsReceptors, Complement

Identifiers

PMID16166590
PMCPMC1895357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.